Revorf Company
Revorf is a company that focuses on developing testing and diagnostic drugs to support the discovery of new drugs related to autoimmune diseases. They use a combination of gene detection analysis technology, protein information analysis technology, data analysis, and artificial intelligence technology to develop their methods. Their work is based on the neo-self theory, which explains the basis of autoimmune diseases.
Founded Date:
2019-11-11
Funding Status:
Seed
Total Funding:
300000000.0
Headquarters:
Tokyo, Tokyo, Japan
Last Funding Date:
2021-03-08
Investors Number:
5.0
Last Funding Type:
Seed
Industry:
Early Drug Development